Bioburden Testing Market 2019 By Size, Share, Applications, Technology and Techniques Receives Growth at a CAGR of 9.15% till 2023

Bioburden Testing Market

Bioburden Testing Market

Bioburden testing, also known as microbial limits testing or microbial enumeration test is a procedure used for the determination of microbial content in raw materials, in-process samples, and finished product in the pharmaceutical, biological, cosmetics, nutritional products, and medical device industry.

The global bioburden testing market is showing significant progress and is expected to reach a valuation of USD 455 Mn at a CAGR of 9.15% by the end of the forecast period of 2018-2023, predicts Market Research Future (MRFR) in a detailed study.

Bioburden testing is standard in quality control of medical devices to ensure suitability of the devices which fosters the growth of the global bioburden testing market. Surging cases of sterility failures, raw material contamination, and requirement to ensure compliance with stringent FDA regulations pertaining to medical device testing has generated demand for bioburden testing.

Get Sample Copy at https://www.marketresearchfuture.com/sample_request/6716

The global bioburden testing market is currently dominated by many market players. The key players in the market are involved in new product launches and strategic collaborations to strengthen its market position. For instance, in October 2018, Becton, Dickinson and Company, a leading global medical technology company, announced the availability of the BD MAX MDR-TB (multi-drug resistant tuberculosis) panel in Europe.

Intended Audience

  • Pharmaceutical Companies
  • Research and Development (R&D) Companies
  • Manufacturers of Food and Beverage Products
  • Diagnostic Laboratories
  • Manufacturers of Agricultural Products
  • Government Research Institutes
  • Academic Institutes and Universities

Segmentation:

The global bioburden testing market has been segmented into test type, product type, application and end-user.

The market, on the basis of type, has been segmented into aerobic count, anaerobic count, fungi count and spore count.

The market, on the basis of product type, has been segmented into consumables and instruments.

The market, by consumables, has been sub-segmented into reagents and kits, and others.

The market, by instruments, has been further segmented into polymerase chain reaction machine (PCR), microscopes, and others.

The market, by application, has been segmented into raw materials testing, medical devices testing, in-process material testing, sterilization validation testing, and equipment cleaning validation.

The market, by end-user, has been segmented into pharmaceutical and biotechnology companies, microbial testing laboratories, and others.

Browse Complete Premium Research Report Enabled with Respective Tables and Figures at https://www.marketresearchfuture.com/reports/bioburden-testing-market-6716

Key Players:

Some of the key players in the global bioburden testing market are WuXi AppTec, Charles River, SGS SA, Merck KGaA, NORTH AMERICAN SCIENCE ASSOCIATES INC., Becton, Dickinson, and Company, Nelson Laboratories, LLC, Pacific Biolabs, ATS Laboratories, Inc., and Dynatec Labs.

Table Of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

Chapter 3. Research Methodology

Chapter 4. Market Dynamics

Chapter 5. Market Factor Analysis

Chapter 6. Global Bioburden Testing Market, By Test Type

Chapter 7. Global Bioburden Testing Market, By Product Type

Chapter 8. Global Bioburden Testing Market, By Application

Chapter 9. Global Bioburden Testing Market, By End-User

Chapter 10 Global Bioburden Testing Market, By Region

Chapter 11. Company Landscape

Chapter 12. Company Profiles

Chapter 13 MRFR Conclusion

Chapter 14. Appendix

  • LIST OF TABLES
  • LIST OF FIGURES

Inquire for Discount at https://www.marketresearchfuture.com/check-discount/6716

Regional Analysis:

The market in the Americas is expected to dominate the global bioburden testing market during the forecast period owing to the presence of well-established healthcare system, increasing healthcare expenditure, and favorable reimbursement scenario. The European market is expected to be the second-largest due to availability of funds for research from public and private sources. Moreover, the market in Asia-Pacific is predicted to be the fastest-growing during the assessment period owing to growing disposable income, and continuously developing economies. The market in the Middle East & Africa is likely to account for the smallest share of the global bioburden testing market. The market growth in this region can be attributed to the growing government initiatives.

About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar, Pune

+1 646 845 9312

Email: sales@marketresearchfuture.com

Leave a Reply

Your email address will not be published. Required fields are marked *